Birdwatch Note
2023-03-30 22:28:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Xylazine is not “flesh eating” (it may cause wounds) and does not “tear through bone.” It is not an opioid so it is not “resistant” to Narcan because Narcan is only an antidote for opioids. Its presence in the drug supply is likely due to DEA efforts to ban/destroy other drugs. https://en.wikipedia.org/wiki/Xylazine
Written by E869CB2545D16F80E5773496CEA2319FF0243270B87C39610F3D5BD892C67EE0
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1641497197110865922
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1641568197773234176
- noteId - 1641568197773234176
- participantId -
- noteAuthorParticipantId - E869CB2545D16F80E5773496CEA2319FF0243270B87C39610F3D5BD892C67EE0 Participant Details
- createdAtMillis - 1680215331871
- tweetId - 1641497197110865922
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Xylazine is not “flesh eating” (it may cause wounds) and does not “tear through bone.” It is not an opioid so it is not “resistant” to Narcan because Narcan is only an antidote for opioids. Its presence in the drug supply is likely due to DEA efforts to ban/destroy other drugs. https://en.wikipedia.org/wiki/Xylazine
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-30 22:28:51 UTC (1680215331871) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-31 02:42:32 UTC (1680230552362) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-30 18:26:24 -0500 | Rating Details | |
| 2023-03-30 18:21:32 -0500 | Rating Details | |
| 2023-03-30 18:19:07 -0500 | Rating Details | |
| 2023-03-30 17:34:37 -0500 | Rating Details | |
| 2023-03-31 03:16:20 -0500 | Rating Details | |
| 2023-03-31 00:45:50 -0500 | Rating Details | |
| 2023-03-30 23:46:48 -0500 | Rating Details | |
| 2023-03-30 22:24:06 -0500 | Rating Details | |
| 2023-03-30 21:19:37 -0500 | Rating Details | |
| 2023-03-30 20:47:04 -0500 | Rating Details | |
| 2023-03-31 21:47:28 -0500 | Rating Details | |
| 2023-03-31 20:28:29 -0500 | Rating Details | |
| 2023-04-03 11:19:03 -0500 | Rating Details | |
| 2023-04-03 09:58:12 -0500 | Rating Details | |
| 2023-03-31 20:28:29 -0500 | Rating Details | |
| 2023-03-30 18:21:32 -0500 | Rating Details | |
| 2023-03-31 21:47:28 -0500 | Rating Details | |
| 2023-03-30 17:34:37 -0500 | Rating Details | |
| 2023-03-30 20:47:04 -0500 | Rating Details | |
| 2023-03-30 18:19:07 -0500 | Rating Details | |
| 2023-04-03 11:19:03 -0500 | Rating Details | |
| 2023-04-03 09:58:12 -0500 | Rating Details | |
| 2023-03-30 18:26:24 -0500 | Rating Details | |
| 2023-03-30 22:24:06 -0500 | Rating Details | |
| 2023-03-31 03:16:20 -0500 | Rating Details | |
| 2023-03-30 23:46:48 -0500 | Rating Details | |
| 2023-03-31 00:45:50 -0500 | Rating Details | |
| 2023-03-30 21:19:37 -0500 | Rating Details |